These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
482 related items for PubMed ID: 22854769
1. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP. Cui RT, Huang XS, Liu JX, Chen ZH, Pu CQ. J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769 [Abstract] [Full Text] [Related]
2. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. Guo X, Qin X, Zhang Y, Huang C, Yu G. J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501 [Abstract] [Full Text] [Related]
3. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. Mauermann ML, Sorenson EJ, Dispenzieri A, Mandrekar J, Suarez GA, Dyck PJ, Dyck PJ. J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441 [Abstract] [Full Text] [Related]
4. Electrophysiological features of patients with POEMS syndrome. Min JH, Hong YH, Lee KW. Clin Neurophysiol; 2005 Apr; 116(4):965-8. PubMed ID: 15792906 [Abstract] [Full Text] [Related]
6. [Neurophysiologic studies of POEMS syndrome and its related diseases]. Xu Y, Song H, Zhang S, Fan D. Zhonghua Yi Xue Za Zhi; 2014 Feb 11; 94(5):356-8. PubMed ID: 24746082 [Abstract] [Full Text] [Related]
7. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, Ohmori S, Mitsuma S, Koga S, Kuwabara S. J Neurol Neurosurg Psychiatry; 2012 May 11; 83(5):476-9. PubMed ID: 22338030 [Abstract] [Full Text] [Related]
8. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome. Cleland JC, Logigian EL, Thaisetthawatkul P, Herrmann DN. Muscle Nerve; 2003 Aug 11; 28(2):189-93. PubMed ID: 12872323 [Abstract] [Full Text] [Related]
9. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Van Asseldonk JT, Van den Berg LH, Kalmijn S, Wokke JH, Franssen H. Brain; 2005 Apr 11; 128(Pt 4):880-91. PubMed ID: 15689367 [Abstract] [Full Text] [Related]
10. Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome. Wang Q, Liu P, Ji LL, Wu S, Feng GD, Wang X, Dong JH. Chin Med J (Engl); 2019 Jul 20; 132(14):1666-1672. PubMed ID: 31268911 [Abstract] [Full Text] [Related]
11. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy. Wang W, Litchy WJ, Mauermann ML, Dyck PJB, Dispenzieri A, Mandrekar J, Dyck PJ, Klein CJ. Muscle Nerve; 2018 Jan 20; 57(1):E8-E13. PubMed ID: 28646568 [Abstract] [Full Text] [Related]
12. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V, Kalita J, Misra UK. Neurol India; 2011 Jan 20; 59(5):664-8. PubMed ID: 22019647 [Abstract] [Full Text] [Related]
13. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W. Przegl Lek; 2007 Jan 20; 64(6):423-30. PubMed ID: 18159852 [Abstract] [Full Text] [Related]
14. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Lozeron P, Mariani LL, Dodet P, Beaudonnet G, Théaudin M, Adam C, Arnulf B, Adams D. Neurology; 2018 Jul 10; 91(2):e143-e152. PubMed ID: 29907605 [Abstract] [Full Text] [Related]
15. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy. Rajabally YA, Jacob S. Clin Neurophysiol; 2006 Sep 10; 117(9):2079-84. PubMed ID: 16859987 [Abstract] [Full Text] [Related]
16. [Comparison of electrophysiological findings between CIDP and HMSN-1]. Hasegawa O, Matsumoto S, Iino M, Kurita R, Kubota Y. No To Shinkei; 1999 May 10; 51(5):411-4. PubMed ID: 10396746 [Abstract] [Full Text] [Related]
17. Diagnostic challenges in POEMS syndrome presenting with polyneuropathy: A case series. Li Y, Valent J, Soltanzadeh P, Thakore N, Katirji B. J Neurol Sci; 2017 Jul 15; 378():170-174. PubMed ID: 28566158 [Abstract] [Full Text] [Related]
18. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy. Harbo T, Andersen H, Jakobsen J. Muscle Nerve; 2008 Aug 15; 38(2):1036-45. PubMed ID: 18642356 [Abstract] [Full Text] [Related]
19. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Stanton M, Pannoni V, Lewis RA, Logigian EL, Naguib D, Shy ME, Cleland J, Herrmann DN. Muscle Nerve; 2006 Oct 15; 34(4):417-22. PubMed ID: 16823858 [Abstract] [Full Text] [Related]
20. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? Capasso M, Torrieri F, Di Muzio A, De Angelis MV, Lugaresi A, Uncini A. Clin Neurophysiol; 2002 Mar 15; 113(3):346-53. PubMed ID: 11897535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]